Is It Possible to Create Antimicrobial Peptides Based on the Amyloidogenic Sequence of Ribosomal S1 Protein of P. aeruginosa?

The development and testing of new antimicrobial peptides (AMPs) represent an important milestone toward the development of new antimicrobial drugs that can inhibit the growth of pathogens and multidrug-resistant microorganisms such as Pseudomonas aeruginosa, Gram-negative bacteria. Most AMPs achiev...

Descripción completa

Detalles Bibliográficos
Autores principales: Grishin, Sergei Y., Domnin, Pavel A., Kravchenko, Sergey V., Azev, Viacheslav N., Mustaeva, Leila G., Gorbunova, Elena Y., Kobyakova, Margarita I., Surin, Alexey K., Makarova, Maria A., Kurpe, Stanislav R., Fadeev, Roman S., Vasilchenko, Alexey S., Firstova, Victoria V., Ermolaeva, Svetlana A., Galzitskaya, Oxana V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469417/
https://www.ncbi.nlm.nih.gov/pubmed/34575940
http://dx.doi.org/10.3390/ijms22189776

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469417/
https://www.ncbi.nlm.nih.gov/pubmed/34575940
http://dx.doi.org/10.3390/ijms22189776

Ejemplares similares